Last reviewed · How we verify
NCT03555760
Patients' Readings of Pre-operative Informed Consent Forms
trial testing Observation of informed consent form readings of all patients who are scheduled for surgery in Informed Consent in 134 participants. Completed in 28 January 2019.
28 January 2019
Quick facts
| Lead sponsor | Ankara University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 134 |
| Start date | 22 May 2018 |
| Primary completion | 28 January 2019 |
| Estimated completion | 28 January 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Observation of informed consent form readings of all patients who are scheduled for surgery
Conditions studied
- Informed Consent — all drugs for Informed Consent →
- Awareness — all drugs for Awareness →
Sponsor
Ankara University
Who can join
18 and older, any sex, with Informed Consent or Awareness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patient informed consent is a form which contains the patient's probable outcome of the procedure to be performed, and the probable risk and benefit of the patient's knowledge of the illness. On the form, completely honest and detailed information based on the facts are shared with the patient. It will be beneficial to both the physician and the patient to make a correct and complete consent procedure. The view, feelings and thoughts including the continuous and mutual understanding effort between the patient individual and the follow-up health team (physician, nurse, etc.) are essential in this sense. The information that must be provided covers all of the following: * The health status of the patient and the diagnosis, * The type of treatment proposed, * The chances of success and duration, * The risk that the treatment modality carries for the patient's health, * The use of medicines and possible side effects, * The consequences of the illness if the hospital does not accept the recommended treatment, * Alternative treatment options and risks. The informed consent is different from the signing of the patient indicating that he approves the procedure to be performed. The main purpose is to provide information to the patient and to understand this knowledge. For this reason, before the signing of the proclamation, it is necessary to ensure that the patient is informed in accordance with his or her own cultural and educational level. In addition, the patient must be audited that he/she understands the given information. The purpose of this study is to investigate whether the informed consent forms given to the patient after informing by the physician were read as the first reflex before signing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03555760
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Informed Consent
Currently open trials in the same condition.
- NCT07303517 — AI-Driven Consent Simplification Study · recruiting
- NCT06192511 — Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening · NA · recruiting
- NCT07074925 — Video-Assisted Informed Consent for Neonatal Lumbar Puncture · NA · active not recruiting
Other Ankara University trials
Trials by the same sponsor.
- NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
- NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
- NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
- NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
- NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03555760 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara University
- Last refreshed: 26 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03555760.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing